Transcript mapping and transregulatory behavior of varicella-zoster virus gene 21, a latency-associated gene

Virology

Volumn 258, Issue 2, 1999, Pages 304-313

  Xia, Dongxiang ^a   Straus, Stephen E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GANGLION; GENE MAPPING; HUMAN; HUMAN CELL; LATENT PERIOD; NORTHERN BLOTTING; OPEN READING FRAME; PRIORITY JOURNAL; START CODON; TATA BOX; TRANSACTIVATION; TRANSCRIPTION INITIATION; VARICELLA ZOSTER VIRUS; VIRUS CAPSID; VIRUS INFECTION;

EID: 0033526521     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9746     Document Type: Article

References (30)

1. Albright A. G., Jenkins F. J. The herpes simplex virus UL37 is phosphorylated in infected cells. J. Virol. 67:1993;4842-4847.
2. Cohen J. I., Seidel K. Generation of Varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc. Natl. Acad. Sci. USA. 90:1993;7376-7380.
3. Cohen, J. I., and Straus, S. E.1996. Varicella-zoster virus and its replication. InFields Virology (B. N. Fields, D. M. Knipe and P. M. Howley, Eds.), 3rd ed., Vol. 2, pp. 2525-2545. Lippincott-Raven Publisher, Philadelphia.
4. Cohrs R. J., Barbour M., Gilden D. H. Varicella-zoster virus (VZV) transcription during latency in human ganglia: Detection of transcripts mapping to gene 21, 29, 62, and 63 in a cDNA library enriched from VZV RNA. J. Virol. 70:1996;2789-2796.
5. Cohrs R. J., Barbour M., Gilden D. H. Varicella-zoster virus gene 21: Transcriptional start site and promoter region. J. Virol. 72:1998;42-47.
6. Cohrs R. J., Barbour M. B., Mahalingam R., Wellish M., Gilden D. H. Varicella-zoster virus (VZV) transcription during latency in human ganglia: Prevalence of VZV gene 21 transcripts in latently infected human ganglia. J. Virol. 69:1995;2674-2678.
7. Cohrs R. J., Srock K., Barbour M. B., Owens G., Mahalingam R., Devlin M. E., Wellish M., Gilden D. H. Varicella-zoster virus (VZV) transcription during latency in human ganglia: Construction of a cDNA library from latently infected human trigeminal ganglia and detection of a VZV transcript. J. Virol. 68:1994;7900-7908.
8. Croen K. D., Ostrove J. M., Dragovic L. J., Straus S. E. Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes. Proc. Natl. Acad. Sci. USA. 85:1988;9773-9777.
9. Davison A. J., Scott J. E. The complete DNA sequence of varicella- zoster virus. J. Gen. Virol. 67:1986;1759-1861.
10. Disney G. H., McKee T. A., Preston C. M., Everett R. D. The product of varicella-zoster virus gene 62 autoregulates its own promoter. J. Gen. Virol. 71:1990;2999-3003.
11. Felser J. M., Kinchington P. R., Inchauspe G., Straus S. E., Ostrove J. M. Cell lines containing varicella-zoster virus open reading frame 62 and expressing the "IE"175 protein complement ICP4 mutants of herpes simplex virus type 1. J. Virol. 62:1988;2076-2082.
12. Gilligan K. Detailed analysis of a family of RNAs transcribed from varicella-zoster virus open reading frame 21 during replication. Virology. 202:1994;992-996.
13. Jackers P., Defechereux P., Baudoux L., Lambert C., Massaer M., Merville-Louis M. P., Rentier B., Piette J. Characterization of regulatory functions of the varicella-zoster virus gene 63-encoded protein. J. Virol. 66:1992;3899-3903.
14. Kinchington P. R., Inchauspe G., Subak-Sharpe J. H., Robey F., Hay J., Ruyechan W. T. Identification and characterization of a varicella-zoster virus DNA-binding protein by using antisera directed against a predicted synthetic oligopeptide. J. Virol. 62:1988;802-809.
15. Kost R. G., Kupinsky H., Straus S. E. Varicella-zoster virus gene 63: Transcript mapping and regulatory activity. Virology. 209:1995;218-224.
16. Lungu O., Panagiotidis C. A., Annunziato P. W., Gershon A. A., Silverstein S. J. Aberrant intracellular localization of varicella-zoster virus regulatory proteins during latency. Proc. Natl. Acad. Sci. USA. 95:1998;7080-7085.
17. Mahalingam R., Lasher R., Wellish M., Cohrs R. J., Gilden D. H. Localization of varicella-zoster virus gene 21 protein virus-infected cells in culture. J. Virol. 72:1998;6832-6837.
18. McLauchlan J., Simpson S., Clements J. B. Herpes simplex virus induces a processing factor that stimulates poly (A) site usage. Cell. 59:1989;1093-1105.
19. Meier J. L., Holman R. P., Croen K. D., Smialik J. E., Straus S. E. Varicella-zoster virus transcription in human trigeminal ganglia. Virology. 193:1993;193-200.
20. Meier J. L., Luo X., Sawadogo M., Straus S. E. The cellular transcription factor USF cooperates with varicella-zoster virus immediately-early protein 62 to symmetrically activate a bidirectional viral promoter. Mol. Cell. Biol. 14:1994;6896-6906.
21. Meier J. L., Straus S. E. Varicella-zoster virus DNA polymerase and major DNA-binding protein genes have overlapping divergent promoters. J. Virol. 67:1993;7573-7581.
22. Moriuchi M., Moriuchi H., Straus S. E., Cohen J. I. Varicella-zoster virus (VZV) virion-associated transactivator open reading frame 62 protein enhances the infectivity of VZV DNA. Virology. 200:1994;297-300.
23. Sambrook J., Fritsch E. F., Maniatis T. Extraction, purification, and analysis of messenger RNA from Eukaryotic cells. Molecular Cloning. 1989;Cold Spring Harbor Laboratory Press, New York. p. 7.3-7.83.
24. Schmitz J. B., Albright A. G., Kinchington P. R., Jenkins F. J. The UL37 protein of herpes simplex virus type 1 is associated with the tegument of purified virions. Virology. 206:1995;1055-1065.
25. Seed B., Sheen J.-Y. A simple phase-extraction assay for chloramphenical acyltransferase activity. Gene. 67:1988;271-277.
26. Shelton L. S., Albright A. G., Ruyechan W. T., Jenkins F. J. Retention of the herpes simplex virus type 1 (HSV-1) UL37 protein on single-stranded DNA columns requires the HSV-1 ICP8 protein. J. Virol. 68:1994;521-525.
27. Straus S. E. Ostrove, J. M. Inchauspe. G., Felser J. M., Freifeld A., Croen K. D., Sawyer M. H. Varicella-zoster virus infections: Biology, natural history, treatment, and prevention. Ann. Intern. Med. 108:1988;221-237.
28. Takahashi M., Okuno Y., Otsuka T., Osame J., Takamizawa A., Sasada T., Kubo T. Development of a live attenuated varicella vaccine. Biken J. 18:1975;25-33.
29. Ward P .L., Ogle W. O., Roizman B. Assemblons: Nuclear structures defined by aggregation of immature capsids and some tegument proteins of herpes simplex virus 1. J. Virol. 70:1996;4623-4631.
30. Zeff R. A., Gopas J., Steinhauer E., Rajan T. V., Nathenson S. G. Analysis of somatic cell H-2 variants to define the structural requirements for Class I antigen expression. J. Immunol. 137:1986;897-903.